Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT)

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Unknown status
CT.gov ID
NCT04452487
Collaborator
(none)
2,500
3
12
833.3
69.5

Study Details

Study Description

Brief Summary

This survey is performed to examine if during the Covid's crisis, the practitionner's have respected the modalities of the law about the end of life, in particular concerning limitations and stop of therapeutics

Condition or Disease Intervention/Treatment Phase
  • Behavioral: decisions of limitations and stop processing

Detailed Description

In the current legislativ context notably the Clayes Leonetti law, a very large majority of ICU (Intensive Care Unit) patients die with the establishement of a procedure for the limitation and cessation of therapeutics (LAT). During a viral pandemic, medical resources can be saturated, limiting reflexive abilities in favour of binary decisions. This sorting of patients leads to LAT that could be performed without the elementary modalities stated by the law. Thus, arbitrary medical decisions made alone could expose patients to unjustified " loss of luck ". Increasing the resources mobilized during a pandemic must not make us forget the quality of care provided for the benefit of quantity. In therefore seems legitimate to keep the LAT modalities to ensure our ethical principles. No work in the literature based on actual facts explores the impact of a pandemic on compliance with and maintenance of ethical principles and the legisltaive framework, in particular as regards the procedures of the application of LAT.

The purpose of this study is to assess whether the terms of the LAT are being complied during a pandemic for patients with or without Covid.

Study Design

Study Type:
Observational
Anticipated Enrollment :
2500 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments
Actual Study Start Date :
Jun 1, 2020
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Patient 2019

Patients hospitalized in selected centers during march and june 2019

Behavioral: decisions of limitations and stop processing
Compliance of the modalities of decisions of limitations and stop processing

Patient 2020

Patients hospitalized in selected centers during march and june 2020 (during COVID-19 pandemia)

Behavioral: decisions of limitations and stop processing
Compliance of the modalities of decisions of limitations and stop processing

Patient 2021

Patients hospitalized in selected centers during march and june 2021

Behavioral: decisions of limitations and stop processing
Compliance of the modalities of decisions of limitations and stop processing

Outcome Measures

Primary Outcome Measures

  1. decisions of limitations and therapeutic stops [at the end of patient's hospitalization, an average of one month]

    The conformity of the modalities of the decisions of limitations and therapeutic stops will be evaluated by a composite criterion defined by the simultaneous presence of the 3 main modalities imposed by the Clayes-Leonetti law to achieve a limitation that are : An outside consultant's opinion ( required if no advance directives), the caregiver collegial discussion or adherence to patient advance directives, notification of decision in the medical record

Secondary Outcome Measures

  1. Characteristics of the notification of LAT procedure [at the end of patient's hospitalization, an average of one month]

    notification of the decision, the conclusions of the discussions, the opinion of the consultant and the arguments given to justify the LAT

  2. Characteristics of the LAT procedure (persons who participated to the collegial discussion) [at the end of patient's hospitalization, an average of one month]

    number and status of caregivers who participated to the collegial discussion

  3. Characteristics of consultant's reasoned opinion for the LAT procedure [at the end of patient's hospitalization, an average of one month]

    formal elements of the consultant's reasoned opinion ( legal term) in the file

  4. Characteristics of the LAT procedure [at the end of patient's hospitalization, an average of one month]

    formal elements of advance directives

  5. Characteristics of units [day 0]

    number of beds, number of caregivers (medical, paramedical, internal external), number of admissions during periods of study

  6. Age of physicians [Day 0]

    measured in year

  7. gendrer of physicians [Day 0]

    male or female

  8. Exparience of physicians [Day 0]

    Measured in year of experience

  9. Characteristics of physicians [Day 0]

    professional status

  10. Age of patients [day 0]

    measured in year

  11. patient's history [day 0]

    comorbidities

  12. COVID-19 patient's status [day 0]

    COVID19 infection (yes or no)

  13. Characteristics of hospitalization's patients [day 0]

    hospitalization reason

  14. Characteristics of affected organ [day 0]

    organ failure

  15. Characteristics of patients [day 0]

    severity score

  16. final patient status [day 0]

    fate

  17. patient's environnement [day 0]

    family presence or relatives

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hospitalized major patient

  • Infected or not with Covid-19

  • having a management with a LAT defined by an anticipated or factual restriction of a therapeutic resource ( organ replacement, specific treatment) while his or her state of health requires or may require it, leading or not a death. The patient's death occurs either after a cariac massagewhich corresponds to a maximum management with therapeutic failure or within the framework or in the context of brain death, in these cases there is no LAT ; either without cardiac massage and in this case there is de facto a LAT wether or not it is performed according to legisltaive procedures. All patients who die will beclassified according to this diagram for the inclusion criterion. For surviving patients, an analysis of the record in search of LAT elments will be performed. In the absence of LAT elment in the record, i twill be considered that the patient did not have LAT and therfore will not be included.

Exclusion Criteria:

None

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Clermont-Ferrand Clermont-Ferrand France 63000
2 Hospices Civiles de Lyon Lyon France 69000
3 CH de Vichy Vichy France 03000

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand

Investigators

  • Principal Investigator: Virginie Guastella, University Hospital, Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT04452487
Other Study ID Numbers:
  • 2020_GUASTELLA_COVID-19-LAT
First Posted:
Jun 30, 2020
Last Update Posted:
Jun 30, 2020
Last Verified:
Jun 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Clermont-Ferrand
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2020